High Percentage Of Heart Patients Receive Off-Label And Untested Drug-Coated Stents

Armen Hareyan's picture
Advertisement

One-year follow-up showed patients receiving stents off-label or untested faired similarly to patients who fit FDA criteria for standard use.

A one-year study of roughly 5,500 patients who underwent angioplasty for the insertion of drug-eluting stents (DES) found that nearly half of those patients

Advertisement